ReiThera Srl is a CDMO company dedicated to technology and process development and GMP manufacturing, providing support for the clinical translation of genetic vaccines and medicinal products for advanced therapies.

The company has extensive expertise in developing scalable processes for viral-vector manufacturing and a consolidated experience in GMP production of Adeno-Associated Vector (AAVx), Lentivirus, Adeno Viral vector (AdV), Modified Vaccinia Ankara and Herpes Simplex Vector.

ReiThera’s core manufacturing capacity is based in a state-of-the-art facility, which includes stirred-tank bioreactors at scales of 50L, 200L, 1000L, and 2000L, as well as fixed-bed bioreactors for cell growth in adherence. The GMP facility also comprises a filling suite and quality control laboratories.

ReiThera’s headquarters, R&D laboratories, and GMP facilities are located in Rome, Italy.

At Miltenyi Bioindustry, we are a global CDMO service provider specializing in advanced cell and gene therapies. We offer comprehensive process development and manufacturing services for both autologous and allogeneic cell therapy programs. With our state-of-the-art manufacturing and analytical solutions from Miltenyi Biotec, we empower customers to conquer the obstacles associated with developing and producing cell-based therapies. Our vertical integration includes lentiviral vector production and delivering quality and regulatory consultation services. With over 25 years of leading expertise, we will propel your breakthroughs and take it to clinical trials and commercialization. Operating across three continents, we deliver standardized and consistent processes that are tailored to meet your regional requirements and unique challenges.